Department of Cardiovascular Surgery, University Heart Center Freiburg, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Interact Cardiovasc Thorac Surg. 2022 Feb 21;34(3):349-353. doi: 10.1093/icvts/ivab352.
To evaluate in-hospital outcomes of concomitant mitral valve replacement (MVR) in patients undergoing conventional aortic valve replacement due to aortic stenosis in a nationwide cohort.
Administrative data from all patients with aortic stenosis undergoing conventional aortic and concomitant MVR (reason for MVR not specified) between 2017 and 2018 in Germany were analysed.
A total of 2597 patients with a preoperative logistic EuroScore of 9.81 (standard deviation: 8.56) were identified. In-hospital mortality was 6.8%. An in-hospital stroke occurred in 3.4%, acute kidney injury in 16.3%, prolonged mechanical ventilation of more than 48 h in 16.3%, postoperative delirium in 15.8% and postoperative pacemaker implantation in 7.6% of the patients. Mean hospital stay was 16.5 (standard deviation: 12.1) days. Age [odds ratio (OR): 1.03; P = 0.019], New York Heart Association class III or IV (OR: 1.63; P = 0.012), previous cardiac surgery (OR: 2.85, P = 0.002), peripheral vascular disease (OR: 2.01, P = 0.031), pulmonary hypertension (OR: 1.63, P = 0.042) and impaired renal function (glomerular filtration rate <15, OR: 3.58, P = 0.001; glomerular filtration rate <30, OR: 2.51, P = 0.037) were identified as independent predictors for in-hospital mortality.
In this nationwide analysis, concomitant aortic and MVR was associated with acceptable in-hospital mortality, morbidity and length of in-hospital stay. The regression analyses may help to identify high-risk patients and further optimize treatment strategies.
在全国范围内的队列中,评估因主动脉瓣狭窄而行传统主动脉瓣置换术的患者同时行二尖瓣置换术(MVR)的住院期间结局。
分析了 2017 年至 2018 年期间德国所有因主动脉瓣狭窄而行传统主动脉瓣置换术和同时行 MVR(未指定 MVR 原因)的患者的行政数据。
共确定了 2597 名术前逻辑 EuroSCORE 为 9.81(标准差:8.56)的患者。住院期间死亡率为 6.8%。3.4%的患者发生院内卒中和 16.3%的患者发生急性肾损伤、16.3%的患者机械通气时间延长超过 48 小时、15.8%的患者发生术后谵妄和 7.6%的患者需要植入术后起搏器。患者平均住院时间为 16.5(标准差:12.1)天。年龄[比值比(OR):1.03;P=0.019]、纽约心脏协会心功能分级 III 或 IV 级(OR:1.63;P=0.012)、既往心脏手术史(OR:2.85,P=0.002)、外周血管疾病(OR:2.01,P=0.031)、肺动脉高压(OR:1.63,P=0.042)和肾功能受损(肾小球滤过率 <15,OR:3.58,P=0.001;肾小球滤过率 <30,OR:2.51,P=0.037)被确定为住院期间死亡率的独立预测因素。
在这项全国性分析中,同时行主动脉瓣和 MVR 与可接受的住院期间死亡率、发病率和住院时间相关。回归分析可以帮助识别高危患者,并进一步优化治疗策略。